This message was sent to ##Email##
|
|
|
|
|
SCAI
On July 5, the U. S. Food and Drug Administration (FDA) provided final approval of the Absorb GT1 Bioresorbable Vascular Scaffold System (BVS) developed to treat patients with coronary artery disease (CAD).
In March, SCAI was the only society to provide testimony on this device to the FDA Circulatory System Devices Panel, which recommended approval of the BVS. In this testimony, SCAI Immediate Past-President James Blankenship, MD, MHCM, MSCAI, concluded that to continue to provide state-of-the-art technology, BVS should be made available for appropriate patients.
Indications for use were posted on the FDA website shortly after the initial announcement, including: "The GT1 BVS is a temporary scaffold that will fully resorb over time and is to be used in patients who have a narrowing in their coronary artery lesions that is less than or equal to 24 mm long with a reference vessel diameter of ≥ 2.5 mm and ≤ 3.75 mm."
Read the FDA announcement.
Read the FDA indications for use.
SCAI
In SCAI's opinion, bundling payments for all different types of coronary artery disease into one payment group is simply unworkable. The severity of the disease is too diverse, and proper treatments are too diverse as well. These bundles are being developed because policymakers felt that patients were being overtreated because of financial incentives to physicians to provide excessive care. If that was true, do policymakers now think that financial incentives to undertreat patients may not have the same affect?
Read more from the letter here
TCTMD
After undergoing successful percutaneous coronary intervention, diabetic patients with acute coronary syndrome have a markedly higher risk of major adverse cardiac events — particularly those arising from nonculprit lesions — when at least one IVUS-identified thin-cap fibroatheroma is present, an analysis of the PROSPECT study shows. But among patients without this feature, outcomes are similar regardless of diabetes status.
READ MORE
Healio
Patients with advanced heart failure who viewed a video outlining various levels of end-of-life care were more likely to choose care that stressed comfort over more invasive care that could prolong life, according to a study published in Circulation. The six-minute-long, physician-narrated video featured information and images about three stages of advanced care.
READ MORE
|
Promoted by
|
|
|
|
 |
The Cardiology Advisor
Patients with heart failure with preserved ejection fraction experience symptoms of breathlessness that were found to be multifactorial and related to body mass index, left ventricular diastolic function and pulmonary vasculature. Daniel Dalos, MD, of the Division of Cardiology at the Medical University of Vienna, and colleagues sought to identify the hemodynamic and other patient-related variables associated with New York Heart Association (NYHA) functional class and to assess NYHA class in relation to other clinical parameters.
READ MORE
JAMA Cardiology via News-Medical.Net
Anemia is common in patients with heart failure, regardless of the underlying phenotype, and is often associated with iron deficiency, U.K. researchers report. Furthermore, both anemia and iron deficiency were associated with increased all-cause and cardiovascular mortality and may therefore "be therapeutic targets in this population," say John Cleland and colleagues, from the University of Hull.
READ MORE
 |
|
Now available with a nitinol wire, meeting preferences for a more durable wire and more tactile feel. Included is a stainless steel needle for single wall, micropuncture technique. Adding to SS and A-Kit options, Terumo now offers a full family of thin wall, introducer sheath kits for additional procedural preferences.
©2016 Terumo Medical Corporation. All rights reserved.
All brand names are trademarks or registered trademarks of Terumo. TIS-310-05242016
|
|
European Heart Journal via News-Medical.Net
Testing high-sensitivity cardiac troponin T levels in patients with acute coronary syndromes reduces their need for cardiac stress testing and speeds their discharge from the emergency department, report researchers. And the introduction of hs-cTnT testing did not result in the "increased or inappropriate use of coronary angiography," Christian Mueller and study co-authors report in the European Heart Journal.
READ MORE
Medscape
The American College of Cardiology and American Heart Association have jointly issued new clinical performance and quality measures for adults with atrial fibrillation or atrial flutter.
The document, published online in the Journal of the American College of Cardiology and Circulation Cardiovascular Quality Outcomes, updates the last version released in February 2008 and related implementation notes issued in 2011.
READ MORE
 |
|
PrognoCIS Electronic Health Record (EHR) and services use the latest internet technologies to provide efficient practice management and medical billing, meeting the needs of Cardiologists around the country.
Learn why our members say we’re “More Than a Great EHR.”
|
|
Cardiovascular Business
Although heart diseases can affect anyone, a new study shows evidence that a certain string of heart failures occur more often in minority athletes than their athletic counterparts of different races and genders.
The study, which involved more than 30 years of research by scientists at Tufts Medical Center in Boston, will be published in the October issue of The American Journal of Medicine.
READ MORE
Pulsara
Repeating the ECG after you've already received one from the medics wastes precious time and tissue. Rethinking that protocol could mean improved outcomes for your patients.
READ MORE
Medscape
For certain elderly patients with severe aortic-valve stenosis who have computed tomography (CT) angiography as part of a workup before transcatheter aortic-valve replacement (TAVR), the CT scan can also accurately rule out obstructive coronary artery disease and spare them from an invasive coronary angiogram, a new study suggests. Specifically, when pre-TAVR CT scans of the heart also show clear images of the coronary arteries that are not obscured by calcification and are free of major stenosis, then patients may not need the more invasive test, Alexia Rossi, MD, reported during a poster session at the Society of Cardiovascular Computed Tomography 2016 Annual Scientific Meeting.
READ MORE
|
Missed last week's issue? See which articles your colleagues read most.
|
|
Don't be left behind. Click here to see what else you missed.
|
| Date |
Event |
Location |
| July 8- 9 |
SDCI 2016: San Diego Cardiovascular Interventions Course |
San Diego, CA
|
| July 28- 29 |
Complex Interventional Cardiovascular Therapy (CICT) 2016 |
San Francisco, CA
|
| Aug. 20-21 |
SCAI-NCDD China Fellows Course
|
Shijiazhuang, CHINA
|
| Aug. 25-28 |
ACC/SCAI Premier Interventional Cardiology Overview and Board Preparatory Course Gold Package
|
Amelia Island, FL
|
| Sept. 30-Oct. 1 |
3rd Annual Chicago CSI: Case Based Coronary and Structural Heart Intervention Update |
Chicago, IL
|
| Oct. 1 |
TRIP-VASC |
Chicago, IL
|
| Dec. 10-14 |
SCAI 2016 Fall Fellows Courses |
Las Vegas, NV
|
| May 10-13, 2017 |
SCAI 2017 Scientific Sessions |
New Orleans, LA
|
| Dec. 9-12, 2017 |
SCAI 2017 Fall Fellows Courses |
Las Vegas, NV
|
For a complete list of job postings, click here.
To post your resume, click here.
|
|
|
|
|
|
|
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
